Actively Recruiting
Evaluating Bleomycin Electrosclerotherapy for Treating Low-flow Vascular Malformations
Led by Institute of Oncology Ljubljana · Updated on 2026-10-09
140
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Vascular malformations are rare abnormalities of blood vessels that range from simple to complex conditions and can occur anywhere in the body. This trial evaluates bleomycin electrosclerotherapy BEST, a new treatment approach combining bleomycin injection with electrical pulses to enhance treatment effectiveness for low-flow vascular malformations, such as venous and lymphatic types. The study is part of an international effort to standardize BEST procedures and improve outcomes where current treatments are often limited or have safety concerns. Participants will receive bleomycin injected directly into the vascular malformation, followed by local application of electrical pulses according to the BEST procedure. This method aims to increase the drugs effect on the malformation, potentially reducing lesion size and symptoms. The treatment focuses on lesions not exceeding 25 cm in length, including skin, mucosal, superficial, or deep-seated lesions. Multiple lesions can be treated, with dosing limited to a maximum bleomycin dose per session. During the study, participants will undergo MRI scans to measure changes in lesion volume at 3 and 12 months after treatment. Researchers will also monitor treatment completion rates, adverse events, and quality of life changes using questionnaires. The study includes follow-up visits up to 12 months after treatment to assess safety and effectiveness. Participant involvement includes receiving the BEST treatment and attending scheduled assessments to evaluate outcomes over time.
CONDITIONS
Brief Title
Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)
Research Team
N
Neža Gros
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here